Home Chord Therapeutics

Chord Therapeutics

Chord Therapeutics

Chord Therapeutics
Category
Business Description
Chord Therapeutics is a clinical stage pharmaceutical company developing drugs for patients with rare, life-threatening and severely disabling diseases. We are advancing our lead drug candidate CRD1 under orphan drug designation for the treatment of neuromyelitis optica spectrum disorders (NMO) and myasthenia gravis (MG)
At Chord Therapeutics, we are dedicated to changing the lives of patients affected by rare diseases that often have no or only limited treatment options.
We are convinced that cladribine’s demonstrated safety and powerful, well-understood pharmacology can provide benefit in a variety of rare disorders and lead to de-risked treatment innovation.
Based in
Geneva
Tags
Biotechnology, Pharmaceutical
Total Funding
Between €10 million-€25 million
Founded
2014
Website
http://www.chordtherapeutics.com/

Articles about Chord Therapeutics:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as Chord Therapeutics? We're happy to assist you with our Startup Sourcing service.